이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Imperial Ginseng Products 대차 대조표 상태

재무 상태 기준 확인 6/6

Imperial Ginseng Products 의 총 주주 지분은 CA$360.7K 이고 총 부채는 CA$0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 CA$393.5K 및 CA$32.8K 입니다.

주요 정보

부채 비율

CA$0

부채

이자 보상 비율	n/a
현금	CA$369.57k
주식	CA$360.73k
총 부채	CA$32.81k
총 자산	CA$393.54k

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: IGP 의 단기 자산 ( CA$393.5K )이 단기 부채( CA$32.8K ).

장기 부채: IGP 에는 장기 부채가 없습니다.

부채 대 자본 내역 및 분석

부채 수준: IGP 부채가 없습니다.

부채 감소: IGP 는) 부채 대 자기자본 비율이 10% 였던 5년 전과 비교하여 부채가 없습니다.

부채 범위: IGP 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: IGP 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

Imperial Ginseng Products 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

First half 2024 earnings released: CA$0.005 loss per share (vs CA$0 in 1H 2023)

Upcoming dividend of CA$2.25 per share

Imperial Ginseng Products Ltd. Announces Cash Distribution, Payable on January 26, 2024

Investor sentiment improves as stock rises 27%

New major risk - Market cap size

Insufficient new directors

First quarter 2024 earnings released: CA$0.015 loss per share (vs CA$0.11 loss in 1Q 2023)

New major risk - Market cap size

Insufficient new directors

Here's Why We Think Imperial Ginseng Products (CVE:IGP) Is Well Worth Watching

Full year 2023 earnings released: EPS: CA$0.38 (vs CA$0.31 in FY 2022)

Imperial Ginseng Products Ltd., Annual General Meeting, Dec 07, 2023

Insufficient new directors

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.05 loss in 3Q 2022)

Insufficient new directors

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.07 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.11 loss per share (vs CA$0.22 profit in 1Q 2022)

Insufficient new directors

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: CA$0.31 (vs CA$0.61 loss in FY 2021)

Imperial Ginseng Products Ltd., Annual General Meeting, Dec 07, 2022

Less than half of directors are independent

Chairman exercised options to buy CA$50k worth of stock.

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.05 loss per share (vs CA$0.03 loss in 3Q 2021)

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Investor sentiment improved over the past week

We Think Imperial Ginseng Products' (CVE:IGP) Robust Earnings Are Conservative

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: CA$0.61 loss per share (vs CA$1.00 loss in FY 2020)

Less than half of directors are independent

Third quarter 2021 earnings released: CA$0.03 loss per share (vs CA$0.11 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CA$0.13 (vs CA$0.07 loss in 2Q 2020)

New 90-day high: CA$0.55

How Much is Imperial Ginseng Products' (CVE:IGP) CEO Getting Paid?

New 90-day high: CA$0.37

First quarter 2021 earnings released: CA$0.57 loss per share

Full year earnings released - CA$1.00 loss per share

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기